Ignite Creation Date:
2025-12-26 @ 10:36 AM
Ignite Modification Date:
2026-03-05 @ 8:30 AM
Study NCT ID:
NCT02949128
Status:
COMPLETED
Last Update Posted:
2024-02-20
First Post:
2016-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of ALXN1210 in Complement Inhibitor Treatment-Naïve Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Sponsor:
Alexion Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-24
Completion Date Type:
ACTUAL
First Submit Date:
2016-10-25
First Submit QC Date:
None
Study First Post Date:
2016-10-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-12-11
Results First Submit QC Date:
None
Results First Post Date:
2020-02-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-24
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL